Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 128

    1.

    Burkitt lymphoma: staging and response evaluation.

    Sandlund JT.

    Br J Haematol. 2012 Mar;156(6):761-5. doi: 10.1111/j.1365-2141.2012.09026.x. Epub 2012 Feb 1. Review.

    PMID:
    22296338
    [PubMed - indexed for MEDLINE]
    2.

    Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia.

    Miles RR, Arnold S, Cairo MS.

    Br J Haematol. 2012 Mar;156(6):730-43. doi: 10.1111/j.1365-2141.2011.09024.x. Epub 2012 Jan 20. Review.

    PMID:
    22260323
    [PubMed - indexed for MEDLINE]
    3.

    Epidemiology: clues to the pathogenesis of Burkitt lymphoma.

    Magrath I.

    Br J Haematol. 2012 Mar;156(6):744-56. doi: 10.1111/j.1365-2141.2011.09013.x. Epub 2012 Jan 20. Review.

    PMID:
    22260300
    [PubMed - indexed for MEDLINE]
    4.

    Burkitt lymphoma and the discovery of Epstein-Barr virus.

    Epstein A.

    Br J Haematol. 2012 Mar;156(6):777-9. doi: 10.1111/j.1365-2141.2011.09008.x. Epub 2012 Jan 11.

    PMID:
    22233499
    [PubMed - indexed for MEDLINE]
    5.

    The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma.

    Mitrovic Z, Bast M, Bierman PJ, Bociek RG, Vose JM, Chan WC, Armitage JO.

    Br J Haematol. 2012 May;157(3):401-3. doi: 10.1111/j.1365-2141.2011.08998.x. Epub 2012 Jan 9. No abstract available.

    PMID:
    22224728
    [PubMed - indexed for MEDLINE]
    6.

    Early relapse and refractory disease remain risk factors in the anthracycline and autologous transplant era for patients with relapsed/refractory classical Hodgkin lymphoma: a single centre intention-to-treat analysis.

    Greaves P, Wilson A, Matthews J, Brown DL, Auer R, Montoto S, Lister TA, Gribben JG.

    Br J Haematol. 2012 Apr;157(2):201-4. doi: 10.1111/j.1365-2141.2011.08993.x. Epub 2012 Jan 9.

    PMID:
    22224653
    [PubMed - indexed for MEDLINE]
    7.

    Improving survival in patients with transformed B cell non Hodgkin lymphoma: consolidation with ⁹⁰Yttrium ibritumomab tiuxetan-BEAM and autologous stem cell transplantation.

    Wondergem MJ, Zijlstra JM, de Rooij M, Visser OJ, Huijgens PC, Zweegman S.

    Br J Haematol. 2012 May;157(3):395-7. doi: 10.1111/j.1365-2141.2011.08991.x. Epub 2012 Jan 9. No abstract available.

    PMID:
    22224561
    [PubMed - indexed for MEDLINE]
    8.

    Neurolymphomatosis in a patient with lymphoblastic lymphoma.

    Wan MY, Ardeshna KM, Bomanji J.

    Br J Haematol. 2012 Mar;156(6):691. doi: 10.1111/j.1365-2141.2011.09002.x. Epub 2012 Jan 6. No abstract available.

    PMID:
    22221268
    [PubMed - indexed for MEDLINE]
    9.

    Guidelines on the investigation and management of follicular lymphoma.

    McNamara C, Davies J, Dyer M, Hoskin P, Illidge T, Lyttelton M, Marcus R, Montoto S, Ramsay A, Wong WL, Ardeshna K; Haemato-oncology Task Force of the British Committee for Standards in Haematology (BCSH); British Society for Haematology Committee.

    Br J Haematol. 2012 Feb;156(4):446-67. doi: 10.1111/j.1365-2141.2011.08969.x. Epub 2011 Dec 23. No abstract available.

    PMID:
    22211428
    [PubMed - indexed for MEDLINE]
    10.

    Racial patterns of extranodal natural killer/T-cell lymphoma, nasal type, in California: a population-based study.

    Ai WZ, Chang ET, Fish K, Fu K, Weisenburger DD, Keegan TH.

    Br J Haematol. 2012 Mar;156(5):626-32. doi: 10.1111/j.1365-2141.2011.08982.x. Epub 2011 Dec 20.

    PMID:
    22188140
    [PubMed - indexed for MEDLINE]
    11.

    Management of children with high-risk Hodgkin lymphoma.

    Kelly KM.

    Br J Haematol. 2011 Dec 20. doi: 10.1111/j.1365-2141.2011.08975.x. [Epub ahead of print]

    PMID:
    22188115
    [PubMed - as supplied by publisher]
    12.

    Ofatumumab demonstrates activity against rituximab-sensitive and -resistant cell lines, lymphoma xenografts and primary tumour cells from patients with B-cell lymphoma.

    Barth MJ, Hernandez-Ilizaliturri FJ, Mavis C, Tsai PC, Gibbs JF, Deeb G, Czuczman MS.

    Br J Haematol. 2012 Feb;156(4):490-8. doi: 10.1111/j.1365-2141.2011.08966.x. Epub 2011 Dec 9.

    PMID:
    22150234
    [PubMed - indexed for MEDLINE]
    13.

    Diffusion-weighted MRI compared to FDG PET-CT in the staging and response assessment of Hodgkin lymphoma.

    Marzolini M, Wong WL, Ardeshna K, Padhani A, D'Sa S.

    Br J Haematol. 2012 Mar;156(5):557. doi: 10.1111/j.1365-2141.2011.08959.x. Epub 2011 Dec 8. No abstract available.

    PMID:
    22150023
    [PubMed - indexed for MEDLINE]
    14.

    Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi.

    Merli F, Luminari S, Ilariucci F, Petrini M, Visco C, Ambrosetti A, Stelitano C, Caracciolo F, Di Renzo N, Angrilli F, Carella AM, Capodanno I, Barbolini E, Galimberti S, Federico M.

    Br J Haematol. 2012 Feb;156(3):346-53. doi: 10.1111/j.1365-2141.2011.08958.x. Epub 2011 Dec 7.

    PMID:
    22145911
    [PubMed - indexed for MEDLINE]
    15.

    Clinical significance of the WHO grades of follicular lymphoma in a population-based cohort of 505 patients with long follow-up times.

    Wahlin BE, Yri OE, Kimby E, Holte H, Delabie J, Smeland EB, Sundström C, Christensson B, Sander B.

    Br J Haematol. 2012 Jan;156(2):225-33. doi: 10.1111/j.1365-2141.2011.08942.x. Epub 2011 Nov 30.

    PMID:
    22126847
    [PubMed - indexed for MEDLINE]
    16.

    The tumour suppressor FOXO3 is a key regulator of mantle cell lymphoma proliferation and survival.

    Obrador-Hevia A, Serra-Sitjar M, Rodríguez J, Villalonga P, Fernández de Mattos S.

    Br J Haematol. 2012 Feb;156(3):334-45. doi: 10.1111/j.1365-2141.2011.08951.x. Epub 2011 Nov 23.

    PMID:
    22107151
    [PubMed - indexed for MEDLINE]
    17.

    RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and 'unclassifiable' highly aggressive B-cell lymphoma.

    Corazzelli G, Frigeri F, Russo F, Frairia C, Arcamone M, Esposito G, De Chiara A, Morelli E, Capobianco G, Becchimanzi C, Volzone F, Saggese M, Marcacci G, De Filippi R, Vitolo U, Pinto A.

    Br J Haematol. 2012 Jan;156(2):234-44. doi: 10.1111/j.1365-2141.2011.08947.x. Epub 2011 Nov 21.

    PMID:
    22098541
    [PubMed - indexed for MEDLINE]
    18.

    Expression of multiple cytokines and CCR4 in primary testicular diffuse large B-cell lymphoma, not otherwise specified, involving the skin.

    Nakayama-Ichiyama S, Iwaki K, Yokote T, Tsuji M, Hirata Y, Hanafusa T.

    Br J Haematol. 2012 Feb;156(4):420. doi: 10.1111/j.1365-2141.2011.08943.x. Epub 2011 Nov 21. No abstract available.

    PMID:
    22098482
    [PubMed - indexed for MEDLINE]
    19.

    Treatment of primary intraocular lymphoma with rituximab, high dose methotrexate, procarbazine, and vincristine chemotherapy, reduced whole-brain radiotherapy, and local ocular therapy.

    Taoka K, Yamamoto G, Kaburaki T, Takahashi T, Araie M, Kurokawa M.

    Br J Haematol. 2012 Apr;157(2):252-4. doi: 10.1111/j.1365-2141.2011.08938.x. Epub 2011 Nov 16. No abstract available.

    PMID:
    22085111
    [PubMed - indexed for MEDLINE]
    20.

    Analysis of very elderly (≥80 years) non-hodgkin lymphoma: impact of functional status and co-morbidities on outcome.

    Nabhan C, Smith SM, Helenowski I, Ramsdale E, Parsons B, Karmali R, Feliciano J, Hanson B, Smith S, McKoy J, Larsen A, Hantel A, Gregory S, Evens AM.

    Br J Haematol. 2012 Jan;156(2):196-204. doi: 10.1111/j.1365-2141.2011.08934.x. Epub 2011 Nov 16.

    PMID:
    22084970
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk